Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivablesReceivables - DoubtfulReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

SeaStar Medical Holding (ICUCW) Liabilities and Shareholders Equity (2023 - 2025)

Historic Liabilities and Shareholders Equity for SeaStar Medical Holding (ICUCW) over the last 3 years, with Q3 2025 value amounting to $15.5 million.

  • SeaStar Medical Holding's Liabilities and Shareholders Equity rose 23863.93% to $15.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $36.2 million, marking a year-over-year increase of 8766.19%. This contributed to the annual value of $4.7 million for FY2024, which is 3378.88% up from last year.
  • Per SeaStar Medical Holding's latest filing, its Liabilities and Shareholders Equity stood at $15.5 million for Q3 2025, which was up 23863.93% from $8.4 million recorded in Q2 2025.
  • SeaStar Medical Holding's 5-year Liabilities and Shareholders Equity high stood at $15.5 million for Q3 2025, and its period low was $2.5 million during Q3 2023.
  • In the last 3 years, SeaStar Medical Holding's Liabilities and Shareholders Equity had a median value of $4.6 million in 2024 and averaged $5.8 million.
  • Within the past 5 years, the most significant YoY rise in SeaStar Medical Holding's Liabilities and Shareholders Equity was 23863.93% (2025), while the steepest drop was 180.88% (2025).
  • Quarter analysis of 3 years shows SeaStar Medical Holding's Liabilities and Shareholders Equity stood at $3.5 million in 2023, then surged by 33.79% to $4.7 million in 2024, then surged by 230.43% to $15.5 million in 2025.
  • Its last three reported values are $15.5 million in Q3 2025, $8.4 million for Q2 2025, and $7.6 million during Q1 2025.